Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Biomerica has commenced shipping initial samples of its COVID-19 IgG/IgM Rapid Test.
read more
Thursday, January 22, 2026
bioMérieux announced the acquisition of Accellix, a company specializing in rapid, automated flow cytometry solutions for cell and gene therapy quality control.
read more
bioMérieux announced an agreement to acquire the assets of Day Zero Diagnostics, a US-based infectious disease diagnostics company using genome sequencing and machine learning to combat the rise of antibiotic-resistant infections. This strategic ...
read more
Thursday, October 19, 2023
Oxford Nanopore and bioMérieux SA announced that bioMérieux is making an immediate £70M investment in Oxford Nanopore.
In addition, bioMérieux expects to make further market purchases of Oxford Nanopore’s shares from time to time, up to a further 3....
read more
Monday, December 18, 2017
The Board of Directors of bioMérieux have approved the appointment of Alexandre Mérieux as Chairman and CEO of the Company, effective immediately.
read more
Biomica has entered a service agreement with Biose Industrie for the scale-up production of its drug candidates, microbial consortia BMC121 & BMC127 for its Immuno-Oncology program.
read more
BiomX announced completion of construction of a new state-of-the-art manufacturing facility.
read more
Biond Biologics has entered into an exclusive worldwide license agreement with Sanofi for the development and commercialization of BND-22.
read more
BiondVax developer of the Universal Flu Vaccine candidate M-001, announced the signing of a MSA with a CRO to conduct the first pivotal, clinical efficacy, Phase 3 trial of M-001.
read more
Tuesday, November 03, 2015
Cytovance Biologics, Inc. announced that it has entered into a Development and Manufacturing Agreement for the production of Phase III batches of a universal flu vaccine, M-001, with BiondVax Pharmaceuticals Ltd. (TASE: BVXV) (NASDAQ: BVXV), a ...
read more
Monday, November 20, 2017
BiondVax announced the signing of the clinical trial agreement for a Phase 2 clinical trial with the the U.S. National Institutes of Health.
read more
Thursday, November 10, 2016
Bionical, an integrated outsourced specialist to the pharmaceutical, biotechnology and public health industry, announced the strategic acquisition of Emas Pharma (Emas), a global Clinical Research Organization.
read more
Bionical Emas, a provider of clinical trial services, announced an exclusive global clinical trial supply agreement with Pharma Resources GmbH, German pharmaceutical company and marketing authorization holder, specialized in oncology.
read more
Thursday, December 16, 2021
Bionique Testing Laboratories LLC, a global provider if mycoplasma testing services for the biologics and life- sciences industries, has been 100% acquired by a subsidiary of Japan- based healthcare pioneer Asahi Kasei Medical Co., Ltd. (Asahi Kasei ...
read more
Tuesday, February 03, 2026
Bionique Testing Laboratories announced the appointment of Andy Bailey, PhD, as President and Chief Executive Officer, effective April 1, 2026.
read more